Maxim Group Downgrades Medivation (MDVN) to Hold Amid Takeover

August 23, 2016 11:56 AM EDT
Get Alerts MDVN Hot Sheet
Price: $81.44 --0%

Rating Summary:
    14 Buy, 18 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 19 | New: 13
Trade MDVN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Maxim Group downgraded Medivation (NASDAQ: MDVN) from Buy to Hold with a price target of $81.50 (from $76.00) after the company agreed to be acquired by Pfizer for $81.50 a share in cash.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $80.42 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Maxim Group

Add Your Comment